Personalised Therapy for Metastatic ADPC Determined by Genetic Testing and Avatar Model Generation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a multicenter, open label, randomised phase II clinical trial for patients with metastatic adenocarcinoma of the pancreas. Patients randomised to the experimental arm will undergone tumoral biopsy before starting first line of treatment and will be administered personalised therapy as second or third line.
Epistemonikos ID: b6bbcf1a7bd6fa65ff84de55f3d154115f14a715
First added on: May 17, 2024